DUBLIN, Ohio, April 29 /PRNewswire/ -- COCSA and Medolutions, LLC are pleased to announce that the Bio-Back Lumbar Orthosis has been awarded the COCSA Seal of Approval. The patented Bio-Back is a licensed product of Medolutions, LLC and is clinically proven to help relieve back pain and restore function. The Bio-Back's small, light-weight design makes it an effective tool in the treatment of low back pain.
The Congress of Chiropractic State Associations was founded in 1969 with the mission of providing an open nonpartisan forum for the advancement of the chiropractic profession through service to its member state associations. The COCSA Seal of Approval is granted to products or services deemed to have exceptional value to our state association members or the chiropractic profession. In speaking of the Bio-Back, First Vice President Dr. Kate Rufolo said, "On behalf of the Board, let me say that the Bio-Back represents the best of what is out there to improve the profession and to benefit our patients. We look forward to working with Medolutions." Additional information about COCSA is available at http://www.cocsa.org.
Medolutions was founded in 2007 to develop a line of pain relief products based on unique and patented design architecture. The Company's initial product is the Bio-Back, with patented features that include "Bilateral Opposing Forces" and a "Lumbar Dome". Together these features help relieve back pain and restore range of movement to improve functional outcomes. The Bio-Back is clinically proven, healthcare reimbursed and provides an effective, drug free and complementary device for the treatment of a wide variety of low back conditions. Medolutions President and CEO, Richard J. Gerace said, "We are very pleased to be associated with COCSA whose mission is vital to the chiropractic profession. Their Board is represented by dedicated professionals who strive for the advancement of the profession, their membership and the patients served. Additional information about Medolutions and the Bio-Back may be found at www.medolutions.com.
Copyright©2010 PR Newswire.
All rights reserved